Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Klatskin Tumor × Radiofrequency Ablation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 36 Neoplasm Metastasis 17 Liver Neoplasms 16 Colorectal Neoplasms 13 Cholangiocarcinoma 11 Lung Neoplasms 9 Pancreatic Neoplasms 8 Colonic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Breast Neoplasms 7 Barrett Esophagus 7 Thyroid Nodule 6 Recurrence 5 Rectal Neoplasms 5 Carcinoma, Renal Cell 5 Thyroid Neoplasms 4 Pain 4 Neoplasms 4 Esophageal Neoplasms 4 Prostatic Neoplasms 3 Leiomyoma 3 Kidney Neoplasms 3 Biliary Tract Neoplasms 3 Bile Duct Neoplasms 3 Agnosia 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Hyperaldosteronism 2 Gallbladder Neoplasms 2 Cancer Pain 2

Interventions

Capecitabine 6 Gemcitabine 5 Cisplatin 5 Liver Transplantation 4 Radiosurgery 3 Fluorouracil 3 toripalimab 2 Specimen Handling 2 Self Expandable Metallic Stents 2 Oxaliplatin 2 Magnetic Resonance Spectroscopy 2 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 2 trisacryl gelatin microspheres 1 tremelimumab 1 trametinib 1 tislelizumab 1 temoporfin 1 sacituzumab govitecan 1 pembrolizumab 1 lenvatinib 1 gemcitabine-oxaliplatin regimen 1 durvalumab 1 dehydroftorafur 1 Tegafur 1 Stents 1 Sorafenib 1 Saline Solution 1 S 1 (combination) 1 Radiofrequency Ablation 1 Platinum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05551299 2025-03-27

CARP

University of Leipzig

Phase 4 Recruiting

Gastrointestinal

Bile Duct Neoplasms, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡